Heterogeneity and Clinical Relevance of Human Adipose Stromal and Progenitor Cells
Diabetes & Metabolism Journal · 2026
DOI: 10.4093/dmj.2025.1182 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Diabetes & Metabolism Journal, 2026. Verfasst von Maxi Albert und 3 weiteren Autor:innen. Beteiligte Einrichtung: Helmholtz Institute for Metabolic, Obesity, and Vascular Research (HI-MAG) of the Helmholtz Zentrum München at the University of Leipzig and Universi…. Hauptthemen laut MEDLINE: Stromal Cells, Stem Cells, Adipose Tissue, White, Adipose Tissue. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 149 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Swedish Research Council Formas, Deutsche Forschungsgemeinschaft, German Diabetes Association.
Abstract (Originalsprache)
Adipose stromal and progenitor cells (ASPCs) represent the largest cell population in human white adipose tissue (WAT). Despite their abundance, ASPC heterogeneity remains less well characterized compared to adipocytes or immune cells. Recent single-cell transcriptome studies provide unprecedented resolution of ASPC diversity and function. This review summarizes state-of-the-art approaches, including high-resolution single-cell methods, classical lineage and functional assays, to define ASPC populations. By systematically comparing recent datasets, we identify evidence for at least eight distinct ASPC-subtypes, which demonstrate specific marker genes and putative functional diversity. Along the adipogenic trajectory, these include uncommitted multipotent progenitors, intermediate and committed preadipocytes, and premature adipocytes. Additional populations comprise specialized anti-adipogenic, profibrotic, inflammatory, and fibroblast-like ASPCs. Other cell types are not consistently detected across studies, reflecting both biological and methodological variability, and the need for further validation studies. Better understanding of ASPC heterogeneity may improve the clinical assessment of metabolic disorders and support their treatment. We further discuss subtype-specific (dys)functions linked to fibrosis, inflammation and impaired adipogenesis and describe their increased abundance in metabolic disease. Together, this review integrates current knowledge on ASPC heterogeneity and highlights its clinical relevance, aiming to provide a unified framework for future studies on WAT remodeling and metabolic dysfunction.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Helmholtz Institute for Metabolic, Obesity, and Vascular Research (HI-MAG) of the Helmholtz Zentrum München at the University of Leipzig and University Hospital Leipzig, Leipzig, Germany.
- Department of Medicine (H7), Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
- LeiCeM-Leipzig Center of Metabolism, Leipzig University, Leipzig, Germany.
Förderung
- Swedish Research Council Formas
- Deutsche Forschungsgemeinschaft
- German Diabetes Association
- European Association for the Study of Diabetes
Zitieren
APA
Albert, M., Nalir, K., Zhong, J., & Massier, L. (2026). Heterogeneity and Clinical Relevance of Human Adipose Stromal and Progenitor Cells. Diabetes & Metabolism Journal. https://doi.org/10.4093/dmj.2025.1182
Vancouver
Albert M, Nalir K, Zhong J, Massier L. Heterogeneity and Clinical Relevance of Human Adipose Stromal and Progenitor Cells. Diabetes & Metabolism Journal. 2026. doi:10.4093/dmj.2025.1182
BibTeX
@article{Albert2026,
author = {Albert, Maxi and Nalir, Khansa and Zhong, Jiawei and Massier, Lucas},
title = {Heterogeneity and Clinical Relevance of Human Adipose Stromal and Progenitor Cells},
journal = {Diabetes & Metabolism Journal},
year = {2026},
doi = {10.4093/dmj.2025.1182}
}
EUVIMED